UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 347

Sortiert nach

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

Cancer treatment reviews, 2011-05, Vol.37 (3), p.212-220

2011

Volltextzugriff (PDF)

GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

International journal of clinical practice (Esher), 2014-05, Vol.68 (5), p.609-617

2014

Volltextzugriff (PDF)

SP-0313: Emerging techniques in treating hepatic malignancy

Radiotherapy and oncology, 2013-03, Vol.106, p.S120-S120

Lencioni, R

2013

Volltextzugriff (PDF)

THU-07 Imaging follow-up after liver-directed therapies: Which method, which response criteria?

Digestive and liver disease, 2013-04, Vol.45, p.S236-S236

Lencioni, R

2013

Volltextzugriff (PDF)

First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) non-interventional study

International journal of clinical practice (Esher), 2012-07, Vol.66 (7), p.675-683

2012

Volltextzugriff (PDF)

Treatment before Liver Transplantation for HCC

Annals of surgical oncology, 2008-04, Vol.15 (4), p.993-1000

2008

Volltextzugriff (PDF)

A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma (HCC) who are at high risk of recurrence after curative hepatic resection

Annals of oncology, 2019-07, Vol.30, p.iv51-iv51

2019

Volltextzugriff (PDF)

A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after curative hepatic resection or ablation: EMERALD-2

Annals of oncology, 2019-07, Vol.30, p.iv59-iv60

2019

Volltextzugriff (PDF)

Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply

Radiology, 2000-10, Vol.217 (1), p.119

2000

Volltextzugriff (PDF)

Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study

International journal of clinical practice (Esher), 2010-07, Vol.64 (8), p.1034-1041

2010

Volltextzugriff (PDF)

Efficacy and Safety of Combination Therapy With Everolimus and Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation

Transplantation proceedings, 2014, Vol.46 (1), p.241-244

2014

Volltextzugriff (PDF)

Guidelines for the Use of Contrast Agents in Ultrasound - January 2004

Ultraschall in der Medizin, 2004-08, Vol.25 (4), p.249-256

2004

Volltextzugriff (PDF)

2219 Intratumoral injection of the oncolytic immunotherapeutic Pexa-Vec (JX-594) in liver tumors and hepatocellular carcinoma: Recommendations for clinical practice

European journal of cancer (1990), 2015-09, Vol.51, p.S405-S406

2015

Volltextzugriff (PDF)

New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice

Digestive and liver disease, 2007-02, Vol.39 (2), p.187-195

2007

Volltextzugriff (PDF)

Enhancing the Role of Ultrasound with Contrast Agents

Lencioni, Riccardo

1. Aufl., 2006

Volltextzugriff (PDF)

Do geometric features of hepatocellular carcinomas correlate with survival following radiofrequency ablation (RFA) with and without lyso-thermosensitive liposomal doxorubicin (LTLD/Thermodox)?

Journal of vascular and interventional radiology, 2016-03, Vol.27 (3), p.S33-S33

2016

Volltextzugriff (PDF)

P0372 : Gideon: A retrospective analysis of prognostic factors for survival

Journal of hepatology, 2015-04, Vol.62, p.S451-S452

2015

Volltextzugriff (PDF)

Abstract No. 234: Segmentation and automated measurements of hepatocellular carcinomas in liver CT scans: Comparison to pathology

Journal of vascular and interventional radiology, 2011, Vol.22 (3), p.S100-S100

2011

Volltextzugriff (PDF)

6500 ORAL Second Interim Results of the GIDEON (Global Investigation of Therapeutic DEcisions in HCC and of Its Treatment With SorafeNib) Study – Barcelona-Clinic Liver Cancer (BCLC) Stage Subgroup Analysis

European journal of cancer (1990), 2011-09, Vol.47, p.S441-S442

2011

Volltextzugriff (PDF)

Abstract No. 149: Combined percutaneous approach with radiofrequency ablation and ethanol injection with a multi-pronged needle for the treatment of large hepatocellular carcinoma: Interim analysis of a prospective, multicenter study

Journal of vascular and interventional radiology, 2011, Vol.22 (3), p.S65-S65

2011

Volltextzugriff (PDF)

Focal Liver Lesions: Detection, Characterization, Ablation

1. Aufl., 2005

Volltextzugriff (PDF)

P-80 Sorafenib in extended patient populations in real-world clinical practice: Baseline characteristics from OPTIMIS and GIDEON

Annals of oncology, 2021-07, Vol.32, p.S124-S125

2021

Volltextzugriff (PDF)

81 GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HCC AND OF ITS TREATMENT WITH SORAFENIB) STUDY FIRST INTERIM RESULTS: SORAFENIB DOSING ACROSS REGIONS AND DISEASE SUBGROUPS

Journal of hepatology, 2011-03, Vol.54, p.S36-S37

2011

Volltextzugriff (PDF)

Focal liver lesions: MR imaging-pathologic correlation

European radiology, 2001-01, Vol.11 (8), p.1374-1388

2001

Volltextzugriff (PDF)

Pulmonary radiofrequency ablation in a single lung patient

Thorax, 2006-09, Vol.61 (9), p.828-829

2006

Volltextzugriff (PDF)

1 – 25 von 347

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(302)
Mit Volltextzugriff
(253)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(170)
Science & Technology
(161)
Life Sciences & Biomedicine
(156)
Female
(103)
Male
(96)
Middle Aged
(84)
Aged
(78)
Biological And Medical Sciences
(75)
Medical Sciences
(71)
Radiology, Nuclear Medicine & Medical Imaging
(67)
Adult
(57)
Oncology
(36)
Contrast Media
(31)
Carcinoma, Hepatocellular - Therapy
(30)
Liver Neoplasms - Therapy
(30)
Liver Neoplasms - Diagnosis
(28)
Ultrasonography
(28)
Liver Neoplasms - Diagnostic Imaging
(27)
Prospective Studies
(27)
Tomography, X-Ray Computed
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Radiologia Medica
(29)
European Radiology
(22)
Journal Of Vascular And Interventional Radiology
(21)
Annals Of Oncology
(20)
Journal Of Clinical Oncology
(12)
Journal Of Hepatology
(12)
Abdominal Imaging
(11)
Radiology
(11)
Acta Radiologica
(9)
American Journal Of Roentgenology
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

SP-0313: Emerging techniques in treating hepatic malignancy

THU-07 Imaging follow-up after liver-directed therapies: Which method, which response criteria?

First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) non-interventional study

Treatment before Liver Transplantation for HCC

A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma (HCC) who are at high risk of recurrence after curative hepatic resection

A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after curative hepatic resection or ablation: EMERALD-2

Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply

Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study

Efficacy and Safety of Combination Therapy With Everolimus and Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation

Guidelines for the Use of Contrast Agents in Ultrasound - January 2004

2219 Intratumoral injection of the oncolytic immunotherapeutic Pexa-Vec (JX-594) in liver tumors and hepatocellular carcinoma: Recommendations for clinical practice

New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice

Enhancing the Role of Ultrasound with Contrast Agents

Do geometric features of hepatocellular carcinomas correlate with survival following radiofrequency ablation (RFA) with and without lyso-thermosensitive liposomal doxorubicin (LTLD/Thermodox)?

P0372 : Gideon: A retrospective analysis of prognostic factors for survival

Abstract No. 234: Segmentation and automated measurements of hepatocellular carcinomas in liver CT scans: Comparison to pathology

6500 ORAL Second Interim Results of the GIDEON (Global Investigation of Therapeutic DEcisions in HCC and of Its Treatment With SorafeNib) Study – Barcelona-Clinic Liver Cancer (BCLC) Stage Subgroup Analysis

Abstract No. 149: Combined percutaneous approach with radiofrequency ablation and ethanol injection with a multi-pronged needle for the treatment of large hepatocellular carcinoma: Interim analysis of a prospective, multicenter study

Focal Liver Lesions: Detection, Characterization, Ablation

P-80 Sorafenib in extended patient populations in real-world clinical practice: Baseline characteristics from OPTIMIS and GIDEON

81 GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HCC AND OF ITS TREATMENT WITH SORAFENIB) STUDY FIRST INTERIM RESULTS: SORAFENIB DOSING ACROSS REGIONS AND DISEASE SUBGROUPS

Focal liver lesions: MR imaging-pathologic correlation

Pulmonary radiofrequency ablation in a single lung patient

Suchergebnisse filtern